All filters
Slidesets
Treatment Experienced GT3 patient with Cirrhosis - Geoffrey McCaughan, MD, PhD
Presented at:
Optimize Workshop: Using DAAs in Patients with Cirrhosis and Liver Recipients 2016
Slidesets
Is Treatment Cost-effective? - Kosh Agarwal, MD
Presented at:
Optimize Workshop: Using DAAs in Patients with Cirrhosis and Liver Recipients 2016
Slidesets
What Are the Treatment Options? - Xavier Forns, MD
Presented at:
Optimize Workshop: Using DAAs in Patients with Cirrhosis and Liver Recipients 2016
Slidesets
When to Treat HCV in a Waiting List Patient? - Stefano Fagiuoli, MD
Presented at:
Optimize Workshop: Using DAAs in Patients with Cirrhosis and Liver Recipients 2016
Slidesets
Achieving SVR in CTP C – MELD Purgatory - Christophe Duvoux, MD
Presented at:
Optimize Workshop: Using DAAs in Patients with Cirrhosis and Liver Recipients 2016
Slidesets
What Are the Treatment Options? - Maria Londoño, MD
Presented at:
Optimize Workshop: Using DAAs in Patients with Cirrhosis and Liver Recipients 2016
Slidesets
Use of HCV+ Donor Grafts - Didier Samuel, MD, PhD
Presented at:
Optimize Workshop: Using DAAs in Patients with Cirrhosis and Liver Recipients 2016
Slidesets
Post-LT Renal Failure and HCV Rx - Peter Ferenci, MD
Presented at:
Optimize Workshop: Using DAAs in Patients with Cirrhosis and Liver Recipients 2016
Slidesets
Obstacles to Treatment: Renal Disease, Ribavirin, DDIs - Michael Charlton, MD
Presented at:
Optimize Workshop: Using DAAs in Patients with Cirrhosis and Liver Recipients 2016
Slidesets
Nutritionists Perspective Lifestyle and Behavioral Structured Interventions-Shira Zelber-Sagi,BSc, RD, PhD slides
Presented at:
Innovations in NAFLD Care Workshop 2022
Slidesets
Pushing for Weight Management Bariatric Interventions Benefits and Considerations-Jörn Schattenberg, MD slides
Presented at:
Innovations in NAFLD Care Workshop 2022
Slidesets
Is NAFLDNASH a Public Health Challenge in 2022-Zobair M. Younossi, MD, MPH, FACG, FACP, AGAF, FAASLD slides
Presented at:
Innovations in NAFLD Care Workshop 2022
Slidesets
The Central Role of Primary Care in the NASH Epidemic Opportunities and Challenges-Helen Jarvis,MD slides
Presented at:
Innovations in NAFLD Care Workshop 2022
Slidesets
The Liver-Heart Axis – Does NASH Drive Cardiovascular Disease- Sven Francque, MD, PhD slides
Presented at:
Innovations in NAFLD Care Workshop 2022
Slidesets
Use of Intelligent Liver Function Testing in General Practice-John Dillon, MB,BS,MD,MRCP(UK),FRCP(Edinburgh) slide
Presented at:
Innovations in NAFLD Care Workshop 2022
Slidesets
Integrating Non-Invasive Tests for NAFLD in Clinical Practice Outside the Liver Space - Which Test and at What Level-Alina Allen, MD slides
Presented at:
Innovations in NAFLD Care Workshop 2022
Slidesets
How to Use Diabetes Drugs for Liver Benefit in Patients with NAFLD, Kenneth Cusi, MD, FACP, FACE slides
Presented at:
Innovations in NAFLD Care Workshop 2022
Slidesets
Liver-Directed Drugs in the Pipeline for Fibrotic NASH,Stephen Harrison, M.D, FACP, FAASLD Col (ret.) slides
Presented at:
Innovations in NAFLD Care Workshop 2022
Slidesets
Pharmacotherapy for Obesity - Improving Body Weight and NAFLD, Naim Alkhouri, MD slides
Presented at:
Innovations in NAFLD Care Workshop 2022
Slidesets
The Road to Comprehensive Models of Care for NAFLD - What Are the Endpoints-Jeffrey Lazarus, PhD, MIH, MA Slides
Presented at:
Innovations in NAFLD Care Workshop 2022